58
Participants
Start Date
October 31, 2008
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
KuvanTM Therapy
BH4 treatment was prescribed by each participant's medical provider, not an intervention that was assigned as part of the current study.
Emory University Genetics Clinic, Decatur
Emory Hospital, CIN/ACTSI, Atlanta
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
Atlanta Clinical and Translational Science Institute
OTHER
Emory University
OTHER